US Patent 11964024 B7H4-targeted antibody-drug conjugates and methods of use thereof
Patent 11964024 was granted and assigned to Mersana Therapeutics on April, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11964024 B7H4-targeted antibody-drug conjugates and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.